ARPC (Arem Pacific) YoY EBITDA Growth: 0.00% (As of Mar. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Arem Pacific YoY EBITDA Growth?

Arem Pacific ARPC -99.89% YoY EBITDA Growth is 0.00% as of Mar. 2024.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Arem Pacific's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 0.00%.

Arem Pacific's EBITDA per Share for the three months ended in Mar. 2024 was $0.00.

Arem Pacific YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Arem Pacific's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arem Pacific YoY EBITDA Growth Chart

Arem Pacific Annual Data
Trend Jun15 Jun16 Jun19 Jun20 Jun21 Jun22 Jun23
YoY EBITDA Growth
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Arem Pacific Quarterly Data
Mar15 Jun15 Sep15 Mar16 Jun16 Sep16 Jun19 Jun20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Arem Pacific YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Arem Pacific's YoY EBITDA Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (A: Jun. 2023 )
=(EBITDA per Share (A: Jun. 2023 )-EBITDA per Share (A: Jun. 2022 ))/ | EBITDA per Share (A: Jun. 2022 ) |
=(0-0)/ | 0 |
=N/A %

Arem Pacific's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(0--0)/ | -0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 0.00% mean?
Arem Pacific (ARPC) has a YoY EBITDA Growth of 0.00% as of Mar. 2024. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Arem Pacific and its competitors.
Is Arem Pacific's YoY EBITDA Growth too high?
Arem Pacific's current YoY EBITDA Growth is 0.00%.
How does Arem Pacific's YoY EBITDA Growth compare to GBNHF and FCHS?
Arem Pacific's YoY EBITDA Growth of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Healthcare Providers & Services company?
A good YoY EBITDA Growth depends on the Healthcare Providers & Services industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Arem Pacific and its competitors. Arem Pacific's current YoY EBITDA Growth is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arem Pacific stock overvalued right now?
Arem Pacific (ARPC) has a current YoY EBITDA Growth of 0.00%. The current YoY EBITDA Growth is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Arem Pacific (ARPC), the current YoY EBITDA Growth is 0.00% as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arem Pacific Business Description

Address 271 Blackburn Road, Mount Waverley, Melbourne, VIC, AUS, 3149
Arem Pacific Corporation is engaged in providing wellness services. The company operates in one industry and one geographical segment, those being Oriental holistic health services and Australia. The Wellness center provides services including Acupressure/Reflexology which is acupuncture without needles, Massage Therapy involving application of soft-tissue manipulation techniques to the body and Cupping involving warming of glass cups through a flammable substance. It also offers Neck, shoulder, back, legs, full body massages and deep tissue and hot oil massage. It derives revenues through the provision of therapeutic health services from its Oriental holistic health centres.